GO:0032379 positive regulation of intracellular lipid transport: Lipid Trafficking Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032379 describes any process that activates or increases the directed movement of lipids within cells, a central node in lipid homeostasis.
• The term is a biological_process child of intracellular lipid transport regulation and is distinct from lipid biosynthesis or extracellular lipid transport.
• Key molecular drivers include INSIG1/2 phosphorylation by PCK1, RTN3 activation under lipid overload, TM4SF5 at mitochondria-lysosome contact sites, and acid sphingomyelinase.
• Dysregulation of intracellular lipid transport contributes to hepatic steatosis, diabetic cardiomyopathy, sepsis-induced lung injury, and cancer metabolic reprogramming.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of transport regulators.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0032379-related genes.
Description
Intracellular lipid transport is the directed movement of lipid molecules between organelles, membranes, and storage compartments within a cell. GO:0032379, positive regulation of intracellular lipid transport, captures the upstream signals and molecular machines that increase the frequency, rate, or extent of this movement. Because lipids are hydrophobic and cannot diffuse freely through the cytosol, cells rely on protein-mediated transfer at membrane contact sites, vesicular carriers, and lipid transfer proteins to route fatty acids, sterols, sphingolipids, and phospholipids to their destinations. This process is fundamental to energy storage, membrane biogenesis, and signaling, and its dysregulation is increasingly linked to metabolic disease and cancer. Researchers study GO:0032379 to understand how cells adapt to nutrient status, how organelles communicate, and how lipid overload or deficiency triggers pathology. For example, the gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 to promote lipogenesis and lipid handling, while lipid overload activates RTN3 to drive lipid droplet biogenesis and cardiac dysfunction. At mitochondria-lysosome contact sites, TM4SF5 coordinates cholesterol export and mitochondrial reprogramming. These findings place positive regulation of intracellular lipid transport at the intersection of metabolism, organelle biology, and disease. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to define the term, outline its mechanisms, list key genes, and describe CRISPR-based methods for functional interrogation. It is written for researchers who need a precise, citable overview of GO:0032379 and its experimental tractability.
positive regulation of intracellular lipid transport At A Glance
| GO ID | GO:0032379 |
|---|---|
| GO term | positive regulation of intracellular lipid transport |
| Ontology | biological_process |
| Synonym | activation of intracellular lipid transport; stimulation of intracellular lipid transport; up regulation of intracellular lipid transport; up-regulation of intracellular lipid transport; upregulation of intracellular lipid transport |
| Major function | Increases the directed movement of lipids within cells, supporting membrane biogenesis, energy storage, and organelle communication |
| Parent term | regulation of intracellular lipid transport |
| Related process | lipid transport, lipid droplet biogenesis, lipogenesis, membrane contact site signaling |
| Disease relevance | Hepatic steatosis, diabetic cardiomyopathy, sepsis-induced lung injury, cancer metabolic reprogramming |
What Is GO:0032379?
GO:0032379, positive regulation of intracellular lipid transport, is a biological process defined by QuickGO as any process that activates or increases the frequency, rate, or extent of the directed movement of lipids within cells. In practical terms, it covers signaling events, protein-protein interactions, and membrane remodeling activities that upregulate the transfer of lipid species such as cholesterol, fatty acids, sphingolipids, and phospholipids between intracellular compartments, including the endoplasmic reticulum, mitochondria, lysosomes, lipid droplets, and plasma membrane.
Why Is positive regulation of intracellular lipid transport Important in Cell Biology?
Positive regulation of intracellular lipid transport is important because it determines how cells allocate lipids to storage, membranes, and signaling pools. When this regulation is excessive or misdirected, lipid overload can drive lipotoxicity, organelle dysfunction, and disease. When it is insufficient, cells fail to maintain membrane integrity and energy homeostasis. Understanding GO:0032379 therefore informs metabolic disease, cancer biology, and organelle contact site research.
• Controls lipid droplet biogenesis and storage, influencing energy balance and lipotoxicity.
• Regulates mitochondrial function through cholesterol export at mitochondria-lysosome contact sites.
• Links gluconeogenesis to lipogenesis via PCK1-mediated INSIG1/2 phosphorylation.
• Contributes to diabetic cardiomyopathy through acid sphingomyelinase and mitochondrial calcium disruption.
• Modulates sepsis-induced lung injury via STING and mitochondrial Drp1/N-GSDMD signaling.
• Supports vascular permeability through PLCβ2-dependent pathways.
• Involves ATG8ylation and tonoplast invagination in vacuole protection.
• Requires cardiolipin and mitochondrial cristae organization for proper lipid handling.
• Provides targets for CRISPR screens in metabolic and cardiovascular disease.
• Offers mechanistic biomarkers for cancer and inflammation.
What Happens During positive regulation of intracellular lipid transport?
Initiation by metabolic and signaling cues
In simple terms: The cell senses it needs more lipids moved around and sends a signal to start the process.
Positive regulation of intracellular lipid transport begins when nutrient or stress signals activate upstream kinases and metabolic enzymes. For example, the gluconeogenic enzyme PCK1 phosphorylates INSIG1/2, which promotes lipogenesis and lipid handling. Lipid overload can also activate RTN3, a reticulon family protein that drives lipid droplet biogenesis. These cues convert metabolic status into increased lipid trafficking capacity.
Membrane contact site assembly
In simple terms: Different organelles come close together to exchange lipids directly.
Membrane contact sites between mitochondria, lysosomes, and the endoplasmic reticulum serve as platforms for lipid transfer. TM4SF5-enriched mitochondria-lysosome contact sites mediate cholesterol export and mitochondrial reprogramming in response to glucose. Cardiolipin and mitochondrial cristae organization are also required for proper lipid handling at these sites. These contact sites increase the efficiency of lipid movement without vesicular transport.
Lipid transfer and carrier activation
In simple terms: Special carrier proteins pick up lipids and deliver them to the right place.
Once contact sites are established, lipid transfer proteins and vesicular carriers move specific lipid species. Acid sphingomyelinase promotes ceramide generation and alters mitochondrial calcium homeostasis, indirectly affecting lipid transport. ATG8ylation-mediated tonoplast invagination mitigates vacuole damage by remodeling lipid membranes. These activities increase the rate and extent of intracellular lipid movement.
Downstream organelle remodeling and storage
In simple terms: The moved lipids change how organelles look and work, and may be stored as fat droplets.
Increased lipid transport leads to lipid droplet expansion, mitochondrial membrane remodeling, and changes in organelle function. RTN3 activation under lipid overload promotes lipid droplet biogenesis and cardiac dysfunction. STING-induced mitochondrial Drp1/N-GSDMD-mediated MtDNA release in sepsis involves lipid transport changes that affect lung injury. PLCβ2 promotes VEGF-induced vascular permeability, linking lipid signaling to endothelial function.
Key Genes Involved in GO:0032379 positive regulation of intracellular lipid transport
The following genes and proteins have been experimentally linked to positive regulation of intracellular lipid transport or its related processes in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCK1 | Phosphorylates INSIG1/2 to promote lipogenesis | Links gluconeogenesis to lipid transport regulation |
| INSIG1 | Substrate of PCK1; regulates SREBP processing | Controls lipogenic gene expression and lipid handling |
| INSIG2 | Substrate of PCK1; regulates SREBP processing | Controls lipogenic gene expression and lipid handling |
| RTN3 | Reticulon protein driving lipid droplet biogenesis | Mediates lipid overload-induced cardiac dysfunction |
| TM4SF5 | Tetraspanin at mitochondria-lysosome contact sites | Regulates cholesterol export and mitochondrial reprogramming |
| SMPD1 | Acid sphingomyelinase; generates ceramide | Promotes diabetic cardiomyopathy via mitochondrial calcium disruption |
| STING | Innate immune adaptor at ER membranes | Links lipid transport to sepsis-induced lung injury |
| DNM1L | Drp1; mitochondrial fission GTPase | Mediates MtDNA release and lung injury |
| GSDMD | N-GSDMD pore-forming protein | Executes inflammatory cell death in sepsis |
| PLCB2 | Phospholipase C beta 2 | Promotes VEGF-induced vascular permeability |
| ATG8 | Ubiquitin-like protein for autophagy | Mediates tonoplast invagination and vacuole protection |
| CRD | Cardiolipin synthase pathway component | Required for mitochondrial cristae organization |
| SREBP1 | Sterol regulatory element-binding protein 1 | Downstream of INSIG1/2 in lipogenesis |
| SREBP2 | Sterol regulatory element-binding protein 2 | Downstream of INSIG1/2 in cholesterol regulation |
| VEGFA | Vascular endothelial growth factor A | Upstream of PLCβ2 in vascular permeability |
| CASP1 | Caspase-1 | Inflammasome component linked to GSDMD activation |
| TFEB | Transcription factor EB | Master regulator of lysosomal and lipid metabolism genes |
How Is positive regulation of intracellular lipid transport Regulated?
Positive regulation of intracellular lipid transport is controlled by nutrient-sensing pathways, phosphorylation cascades, and organelle contact site dynamics. PCK1-mediated phosphorylation of INSIG1/2 directly activates lipogenic programs. Glucose availability regulates TM4SF5 at mitochondria-lysosome contact sites, linking energy status to cholesterol export. Lipid overload activates RTN3, creating a feed-forward loop for lipid droplet biogenesis. Inflammatory signals through STING and GSDMD also modulate lipid transport during sepsis. These layers of regulation ensure that lipid movement matches cellular demand and stress.
positive regulation of intracellular lipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCK1 | Hepatic steatosis, metabolic syndrome | Liver-specific knockout or point-mutation knock-in in HepG2 or primary hepatocytes |
| RTN3 | Cardiac dysfunction, lipid overload | Cardiomyocyte-specific overexpression or knockout in H9c2 cells |
| TM4SF5 | Cancer metabolic reprogramming | Knockout and tagged knock-in in cancer cell lines |
| SMPD1 | Diabetic cardiomyopathy | Point-mutation knock-in in cardiomyocytes |
| STING | Sepsis-induced lung injury | Knockout in macrophages or lung epithelial cells |
Metabolic and hepatic disease
PCK1 phosphorylation of INSIG1/2 promotes lipogenesis and is implicated in hepatic steatosis and metabolic syndrome. Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis, linking intracellular lipid transport to cardiomyopathy. Acid sphingomyelinase promotes diabetic cardiomyopathy via disruption of mitochondrial calcium homeostasis, showing how lipid transport regulators contribute to heart disease.
Cancer and metabolic reprogramming
TM4SF5-enriched mitochondria-lysosome contact sites mediate glucose-dependent cholesterol export and mitochondrial reprogramming, supporting cancer cell metabolic adaptation. Altered intracellular lipid transport can supply membranes and signaling lipids for tumor growth, making this process a potential therapeutic target.
Inflammation and sepsis
Inhibition of STING-induced mitochondrial Drp1/N-GSDMD-mediated MtDNA release alleviates sepsis-induced lung injury, implicating lipid transport and mitochondrial dynamics in inflammatory organ damage. PLCβ2 promotes VEGF-induced vascular permeability, connecting lipid signaling to endothelial barrier function.
From positive regulation of intracellular lipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PCK1-mediated INSIG1/2 phosphorylation required for lipid transport? | Point-mutation knock-in of phospho-deficient INSIG1/2 |
| Does RTN3 drive lipid droplet biogenesis under lipid overload? | RTN3 knockout and overexpression in cardiomyocytes |
| How does TM4SF5 regulate cholesterol export at contact sites? | TM4SF5 knockout and tagged knock-in in cancer cells |
| What is the role of acid sphingomyelinase in diabetic cardiomyopathy? | SMPD1 knockout and point-mutation knock-in in cardiomyocytes |
| Does STING-dependent lipid transport affect sepsis lung injury? | STING knockout in macrophages and lung epithelial cells |
| Can ATG8ylation modulate vacuole lipid remodeling? | ATG8 knockout and knock-in in yeast or plant cells |
How to Study the positive regulation of intracellular lipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Test if a gene is required for lipid transport |
| Point-mutation knock-in | Specific residue function | Test phosphorylation sites in INSIG1/2 |
| Lipid droplet imaging | Lipid storage and droplet dynamics | Assess RTN3-driven biogenesis |
| Proximity labeling | Contact site protein composition | Map TM4SF5 interactome |
| Phosphoproteomics | Kinase substrate identification | Find PCK1 targets |
| Lipidomics | Lipid species quantification | Measure transport flux changes |
| Mitochondrial calcium assay | Organelle calcium homeostasis | Link acid sphingomyelinase to cardiomyopathy |
| RNA-seq | Transcriptional changes | Identify compensatory pathways |
CRISPR knockout and point-mutation models
CRISPR-Cas9 knockout of candidate genes such as PCK1, RTN3, or TM4SF5 allows loss-of-function assessment of intracellular lipid transport. Point-mutation knock-in can test specific phosphorylation sites, such as INSIG1/2 residues targeted by PCK1. These models are essential for causal inference in metabolic pathways.
Lipid imaging and organelle tracking
Fluorescent lipid analogs, lipid droplet dyes, and organelle-targeted reporters visualize lipid transport in live cells. Mitochondria-lysosome contact sites can be tracked using split-fluorescent protein systems or proximity labeling. Cardiolipin and cristae organization can be assessed by electron microscopy.
Transcriptomics and proteomics
RNA-seq and proteomics identify global changes in lipid transport gene expression after knockout or overexpression. Phosphoproteomics can map PCK1-dependent phosphorylation of INSIG1/2. Lipidomics quantifies changes in lipid species and storage.
Functional assays for lipid transport
Lipid uptake, efflux, and transfer assays using radiolabeled or fluorescent lipids measure transport rates. Mitochondrial calcium and membrane potential assays link lipid transport to organelle function. Inflammatory and cell death readouts assess downstream consequences.
How CRISPR Can Be Used to Study GO:0032379 positive regulation of intracellular lipid transport
Knockout
CRISPR knockout of genes such as PCK1, RTN3, or TM4SF5 provides definitive loss-of-function evidence for their role in positive regulation of intracellular lipid transport. Knockout cell lines can be used for lipid imaging, lipidomics, and metabolic assays to quantify transport defects.
Point Mutation
Point-mutation knock-in allows precise testing of phosphorylation sites and catalytic residues. For example, mutating PCK1 target sites on INSIG1/2 can determine whether phosphorylation is required for lipogenesis and lipid transport. This approach avoids confounding effects of complete protein loss.
Knock-in
Tagged knock-in of genes like TM4SF5 or RTN3 enables live-cell imaging and proximity labeling at endogenous expression levels. Fluorescent or epitope tags facilitate tracking of protein localization to contact sites and lipid droplets.
Overexpression
Overexpression of RTN3 or TM4SF5 can mimic lipid overload or metabolic stress conditions, revealing sufficiency for lipid transport activation. Overexpression models are useful for gain-of-function screens and for testing downstream consequences such as cardiac dysfunction.
How EDITGENE Supports positive regulation of intracellular lipid transport Research
Researchers studying positive regulation of intracellular lipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid movement, and which domains or residues are required. EDITGENE provides validated CRISPR cell models and screening services to answer these questions with publication-ready rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of intracellular lipid transport research.
Frequently Asked Questions About positive regulation of intracellular lipid transport
What is GO:0032379?
GO:0032379 is the Gene Ontology term for positive regulation of intracellular lipid transport, defined as any process that activates or increases the directed movement of lipids within cells.
What genes are involved in positive regulation of intracellular lipid transport?
Key genes include PCK1, INSIG1, INSIG2, RTN3, TM4SF5, SMPD1, STING, DNM1L, GSDMD, PLCB2, ATG8, and cardiolipin-related genes.
How is intracellular lipid transport regulated?
It is regulated by nutrient-sensing kinases such as PCK1, lipid overload signals through RTN3, glucose-dependent TM4SF5 at contact sites, and inflammatory pathways involving STING and GSDMD.
What diseases are linked to intracellular lipid transport?
Hepatic steatosis, diabetic cardiomyopathy, sepsis-induced lung injury, cancer metabolic reprogramming, and vascular permeability have been linked to this process.
What is the role of PCK1 in lipid transport?
PCK1 phosphorylates INSIG1/2 to promote lipogenesis and lipid handling, linking gluconeogenesis to intracellular lipid transport.
How does RTN3 affect lipid droplets?
RTN3 activation under lipid overload promotes lipid droplet biogenesis and contributes to cardiac dysfunction.
What are mitochondria-lysosome contact sites?
These are membrane contact sites where mitochondria and lysosomes exchange lipids and signals; TM4SF5 enrichment mediates cholesterol export and mitochondrial reprogramming.
Can CRISPR be used to study intracellular lipid transport?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models are widely used to dissect gene function in lipid transport.
What methods measure intracellular lipid transport?
Lipid imaging, lipidomics, phosphoproteomics, proximity labeling, and functional lipid uptake/efflux assays are commonly used.
Why is cardiolipin important for lipid transport?
Cardiolipin is required for mitochondrial cristae organization, which supports proper lipid handling and organelle function.
Conclusion
GO:0032379, positive regulation of intracellular lipid transport, is a central biological process that coordinates lipid movement between organelles in response to metabolic and stress signals. Its molecular players, including PCK1, INSIG1/2, RTN3, TM4SF5, and acid sphingomyelinase, are linked to major diseases such as hepatic steatosis, diabetic cardiomyopathy, sepsis, and cancer. Understanding this process requires precise genetic models and functional assays. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with lipid imaging and omics, provide a robust toolkit for dissecting GO:0032379. EDITGENE offers these services to help researchers move from candidate gene to causal mechanism efficiently.
References
- 1. Xu D et al.. 2020. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.. Nature 580(7804):530-535 PMID: 32322062
- 2. Guo D et al.. 2024. Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis.. Cell Death Differ 31(3):292-308 PMID: 38017147
- 3. Kim JE et al.. 2024. Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites.. Cancer Commun (Lond) 44(1):47-75 PMID: 38133457
- 4. Wei Y et al.. 2025. Acid sphingomyelinase promotes diabetic cardiomyopathy via disruption of mitochondrial calcium homeostasis.. Cardiovasc Diabetol 24(1):272 PMID: 40640752
- 5. Zou S et al.. 2025. Inhibition of STING-induced mitochondrial Drp1/N-GSDMD-mediated MtDNA release alleviates Sepsis-induced lung injury.. Cell Mol Life Sci 82(1):305 PMID: 40779242
- 6. Phoenix KN et al.. 2022. PLCβ2 Promotes VEGF-Induced Vascular Permeability.. Arterioscler Thromb Vasc Biol 42(10):1229-1241 PMID: 35861069
- 7. Zheng X et al.. 2025. ATG8ylation-mediated tonoplast invagination mitigates vacuole damage.. Nat Commun 16(1):6621 PMID: 40681515
- 8. Ikon N et al.. 2017. Cardiolipin and mitochondrial cristae organization.. Biochim Biophys Acta Biomembr 1859(6):1156-1163 PMID: 28336315
